{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:11:08Z","timestamp":1790676668595,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.7759\/cureus.38544","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T13:21:21Z","timestamp":1683206481000},"source":"Crossref","is-referenced-by-count":28,"title":["Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Saikumar","family":"Aramadaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raam","family":"Mannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopal","family":"Sankara Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu R","family":"Yanamaladoddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Suseel","family":"Sarvepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree Laya","family":"Vemula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer's disease","volume":"65","author":"De-Paula VJ","year":"2012","unstructured":"De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer's disease. Subcell Biochem. 2012, 65:329-52. 10.1007\/978-94-007-5416-4_14","journal-title":"Subcell Biochem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer's disease: past, present, and future","volume":"23","author":"Bondi MW","year":"2017","unstructured":"Bondi MW, Edmonds EC, Salmon DP. Alzheimer's disease: past, present, and future. J Int Neuropsychol Soc. 2017, 23:818-31. 10.1017\/S135561771700100X","journal-title":"J Int Neuropsychol Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","unstructured":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050. an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022, 7:e105-25. 10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318820","article-title":"Survival in memory clinic cohort is short, even in young-onset dementia","volume":"90","author":"Rhodius-Meester HF","year":"2019","unstructured":"Rhodius-Meester HF, Tijms BM, Lemstra AW, et al.. Survival in memory clinic cohort is short, even in young-onset dementia. J Neurol Neurosurg Psychiatry. 2019, 90:726-8. 10.1136\/jnnp-2018-318820","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.1971","article-title":"Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging-Alzheimer\u2019s Association research framework","volume":"76","author":"Jack CR Jr","year":"2019","unstructured":"Jack CR Jr, Therneau TM, Weigand SD, et al.. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging-Alzheimer\u2019s Association research framework. JAMA Neurol. 2019, 76:1174-83. 10.1001\/jamaneurol.2019.1971","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"19","author":"Ballard C","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011, 19:1019-31. 10.1016\/S0140-6736(10)61349-9","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack CR Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al.. Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018, 14:535-62. 10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy053","article-title":"Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing","volume":"141","author":"Chhatwal JP","year":"2018","unstructured":"Chhatwal JP, Schultz AP, Johnson KA, et al.. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain. 2018, 141:1486-500. 10.1093\/brain\/awy053","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1996.tb02942.x","article-title":"The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study","volume":"44","author":"Jost BC","year":"1996","unstructured":"Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc. 1996, 44:1078-81. 10.1111\/j.1532-5415.1996.tb02942.x","journal-title":"J Am Geriatr Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer's disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri A","year":"2019","unstructured":"Atri A. The Alzheimer's disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019, 103:263-93. 10.1016\/j.mcna.2018.10.009","journal-title":"Med Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller J","year":"2018","unstructured":"Weller J, Budson A. Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res. 2018, 7:10.12688\/f1000research.14506.1","journal-title":"F1000Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S228939","article-title":"Alzheimer's disease - why we need early diagnosis","volume":"9","author":"Rasmussen J","year":"2019","unstructured":"Rasmussen J, Langerman H. Alzheimer's disease - why we need early diagnosis. Degener Neurol Neuromuscul Dis. 2019, 9:123-30. 10.2147\/DNND.S228939","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"ref13","unstructured":"Why early diagnosis of dementia is important. (2015). https.\/\/www.scie.org.uk\/dementia\/symptoms\/diagnosis\/early-diagnosis.asp."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e3281e20a12","article-title":"Imaging in dementia with Lewy bodies: a review","volume":"28","author":"Kemp PM","year":"2007","unstructured":"Kemp PM, Holmes C. Imaging in dementia with Lewy bodies: a review. Nucl Med Commun. 2007, 28:511-9. 10.1097\/MNM.0b013e3281e20a12","journal-title":"Nucl Med Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease","volume":"2","author":"Johnson KA","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012, 2:a006213. 10.1101\/cshperspect.a006213","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak H","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-59. 10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi L","year":"2013","unstructured":"Mosconi L. Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies. Clin Transl Imaging. 2013, 1:10.1007\/s40336-013-0026-y","journal-title":"Clin Transl Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.5.750","article-title":"Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia","volume":"58","author":"Jack CR Jr","year":"2002","unstructured":"Jack CR Jr, Dickson DW, Parisi JE, et al.. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002, 58:750-7. 10.1212\/wnl.58.5.750","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.10.1476","article-title":"Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study","volume":"58","author":"Gosche KM","year":"2002","unstructured":"Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. 2002, 58:1476-82. 10.1212\/wnl.58.10.1476","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(99)00476-5","article-title":"The histological validation of post-mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease","volume":"95","author":"Bobinski M","year":"2000","unstructured":"Bobinski M, de Leon MJ, Wegiel J, et al.. The histological validation of post-mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience. 2000, 95:721-5. 10.1016\/s0306-4522(99)00476-5","journal-title":"Neuroscience"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.52.6.1153","article-title":"Medial temporal lobe atrophy on MRI in dementia with Lewy bodies","volume":"52","author":"Barber R","year":"1999","unstructured":"Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology. 1999, 52:1153-8. 10.1212\/wnl.52.6.1153","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.12.038","article-title":"Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease","volume":"36","author":"Mak E","year":"2015","unstructured":"Mak E, Su L, Williams GB, Watson R, Firbank MJ, Blamire AM, O'Brien JT. Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease. Neurobiol Aging. 2015, 36:1743-50. 10.1016\/j.neurobiolaging.2014.12.038","journal-title":"Neurobiol Aging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.20934","article-title":"Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease","volume":"31","author":"Mueller SG","year":"2010","unstructured":"Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp. 2010, 31:1339-47. 10.1002\/hbm.20934","journal-title":"Hum Brain Mapp"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/1573405615666190327102052","article-title":"One-year follow-up study of hippocampal subfield atrophy in Alzheimer\u2019s disease and normal aging","volume":"15","author":"Madusanka N","year":"2019","unstructured":"Madusanka N, Choi HK, So JH, Choi BK, Park HG. One-year follow-up study of hippocampal subfield atrophy in Alzheimer\u2019s disease and normal aging. Curr Med Imaging Rev. 2019, 15:699-709. 10.2174\/1573405615666190327102052","journal-title":"Curr Med Imaging Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhh200","article-title":"Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy","volume":"15","author":"Lerch JP","year":"2005","unstructured":"Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex. 2005, 15:995-1001. 10.1093\/cercor\/bhh200","journal-title":"Cereb Cortex"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008782.pub4","article-title":"Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"2014","author":"Ritchie C","year":"2014","unstructured":"Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014, 2014:CD008782. 10.1002\/14651858.CD008782.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.01.002","article-title":"Fluid and imaging biomarkers for Alzheimer's disease: where we stand and where to head to","volume":"107","author":"Henriques AD","year":"2018","unstructured":"Henriques AD, Benedet AL, Camargos EF, Rosa-Neto P, N\u00f3brega OT. Fluid and imaging biomarkers for Alzheimer's disease: where we stand and where to head to. Exp Gerontol. 2018, 107:169-77. 10.1016\/j.exger.2018.01.002","journal-title":"Exp Gerontol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-020-00164-8","article-title":"The role of brain structural magnetic resonance imaging in the assessment of hippocampal subfields in Alzheimer\u2019s disease","volume":"53","author":"Saad SS","year":"2020","unstructured":"Saad SS, Alashwah MM, Alsafa AA, et al.. The role of brain structural magnetic resonance imaging in the assessment of hippocampal subfields in Alzheimer\u2019s disease. Egypt J Radiol Nucl Med 51. 2020, 53:10.1186\/s43055-020-00164-8","journal-title":"Egypt J Radiol Nucl Med 51"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-014-0087-9","article-title":"Imaging endpoints for clinical trials in Alzheimer's disease","volume":"6","author":"Cash DM","year":"2014","unstructured":"Cash DM, Rohrer JD, Ryan NS, Ourselin S, Fox NC. Imaging endpoints for clinical trials in Alzheimer's disease. Alzheimers Res Ther. 2014, 6:87. 10.1186\/s13195-014-0087-9","journal-title":"Alzheimers Res Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009628.pub2","article-title":"Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment","volume":"3","author":"Lombardi G","year":"2020","unstructured":"Lombardi G, Crescioli G, Cavedo E, et al.. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment. Cochrane Database Syst Rev. 2020, 3:CD009628. 10.1002\/14651858.CD009628.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz136","article-title":"Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy","volume":"142","author":"Firth NC","year":"2019","unstructured":"Firth NC, Primativo S, Marinescu RV, et al.. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy. Brain. 2019, 142:2082-95. 10.1093\/brain\/awz136","journal-title":"Brain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/35084005","article-title":"Neurophysiological investigation of the basis of the fMRI signal","volume":"412","author":"Logothetis NK","year":"2001","unstructured":"Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 2001, 412:150-7. 10.1038\/35084005","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.1.44","article-title":"fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease","volume":"74","author":"Sperling RA","year":"2003","unstructured":"Sperling RA, Bates JF, Chua EF, et al.. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003, 74:44-50. 10.1136\/jnnp.74.1.44","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504136102","article-title":"The human brain is intrinsically organized into dynamic, anticorrelated functional networks","volume":"102","author":"Fox MD","year":"2005","unstructured":"Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A. 2005, 102:9673-8. 10.1073\/pnas.0504136102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2008.10.005","article-title":"Patterns of brain activity during a semantic task differentiate normal aging from early Alzheimer's disease","volume":"173","author":"McGeown WJ","year":"2009","unstructured":"McGeown WJ, Shanks MF, Forbes-McKay KE, Venneri A. Patterns of brain activity during a semantic task differentiate normal aging from early Alzheimer's disease. Psychiatry Res. 2009, 173:218-27. 10.1016\/j.pscychresns.2008.10.005","journal-title":"Psychiatry Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-005-2794-x","article-title":"FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease","volume":"16","author":"Yetkin FZ","year":"2006","unstructured":"Yetkin FZ, Rosenberg RN, Weiner MF, Purdy PD, Cullum CM. FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur Radiol. 2006, 16:193-206. 10.1007\/s00330-005-2794-x","journal-title":"Eur Radiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/NPT.0b013e3182462ea6","article-title":"Evidence of altered corticomotor system connectivity in early-stage Alzheimer's disease","volume":"36","author":"Vidoni ED","year":"2012","unstructured":"Vidoni ED, Thomas GP, Honea RA, Loskutova N, Burns JM. Evidence of altered corticomotor system connectivity in early-stage Alzheimer's disease. J Neurol Phys Ther. 2012, 36:8-16. 10.1097\/NPT.0b013e3182462ea6","journal-title":"J Neurol Phys Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2008.11.002","article-title":"The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study","volume":"172","author":"Thiyagesh SN","year":"2009","unstructured":"Thiyagesh SN, Farrow TF, Parks RW, et al.. The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study. Psychiatry Res. 2009, 172:109-16. 10.1016\/j.pscychresns.2008.11.002","journal-title":"Psychiatry Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2174\/156720509790147142","article-title":"An fMRI stroop task study of prefrontal cortical function in normal aging, mild cognitive impairment, and Alzheimer's disease","volume":"6","author":"Li C","year":"2009","unstructured":"Li C, Zheng J, Wang J, Gui L, Li C. An fMRI stroop task study of prefrontal cortical function in normal aging, mild cognitive impairment, and Alzheimer's disease. Curr Alzheimer Res. 2009, 6:525-30. 10.2174\/156720509790147142","journal-title":"Curr Alzheimer Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2009.07.003","article-title":"Amyloid deposition is associated with impaired default network function in older persons without dementia","volume":"63","author":"Sperling RA","year":"2009","unstructured":"Sperling RA, Laviolette PS, O'Keefe K, et al.. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009, 63:178-88. 10.1016\/j.neuron.2009.07.003","journal-title":"Neuron"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2007.11.030","article-title":"Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies","volume":"46","author":"Dickerson BC","year":"2008","unstructured":"Dickerson BC, Sperling RA. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia. 2008, 46:1624-35. 10.1016\/j.neuropsychologia.2007.11.030","journal-title":"Neuropsychologia"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0135058100","article-title":"Functional connectivity in the resting brain: a network analysis of the default mode hypothesis","volume":"100","author":"Greicius MD","year":"2003","unstructured":"Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003, 100:253-8. 10.1073\/pnas.0135058100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI","volume":"101","author":"Greicius MD","year":"2004","unstructured":"Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004, 101:4637-42. 10.1073\/pnas.0308627101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00143","article-title":"Altered functional connectivity of cognitive-related cerebellar subregions in Alzheimer\u2019s disease","volume":"9","author":"Zheng W","year":"2017","unstructured":"Zheng W, Liu X, Song H, Li K, Wang Z. Altered functional connectivity of cognitive-related cerebellar subregions in Alzheimer\u2019s disease. Front Aging Neurosci. 2017, 9:143. 10.3389\/fnagi.2017.00143","journal-title":"Front Aging Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21269","article-title":"Attention-related networks in Alzheimer's disease: a resting functional MRI study","volume":"33","author":"Li R","year":"2012","unstructured":"Li R, Wu X, Fleisher AS, Reiman EM, Chen K, Yao L. Attention-related networks in Alzheimer's disease: a resting functional MRI study. Hum Brain Mapp. 2012, 33:1076-88. 10.1002\/hbm.21269","journal-title":"Hum Brain Mapp"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2174\/15672050113109990146","article-title":"Impaired functional connectivity of the thalamus in Alzheimer's disease and mild cognitive impairment: a resting-state fMRI study","volume":"10","author":"Zhou B","year":"2013","unstructured":"Zhou B, Liu Y, Zhang Z, et al.. Impaired functional connectivity of the thalamus in Alzheimer's disease and mild cognitive impairment: a resting-state fMRI study. Curr Alzheimer Res. 2013, 10:754-66. 10.2174\/15672050113109990146","journal-title":"Curr Alzheimer Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.06.021","article-title":"Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups","volume":"47","author":"Fleisher AS","year":"2009","unstructured":"Fleisher AS, Sherzai A, Taylor C, Langbaum JB, Chen K, Buxton RB. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage. 2009, 47:1678-90. 10.1016\/j.neuroimage.2009.06.021","journal-title":"Neuroimage"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7711-x","article-title":"Recent imaging advances in neurology","volume":"262","author":"Rocchi L","year":"2015","unstructured":"Rocchi L, Niccolini F, Politis M. Recent imaging advances in neurology. J Neurol. 2015, 262:2182-94. 10.1007\/s00415-015-7711-x","journal-title":"J Neurol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.20827","article-title":"Test-retest reliability of fMRI verbal episodic memory paradigms in healthy older adults and in persons with mild cognitive impairment","volume":"30","author":"Cl\u00e9ment F","year":"2009","unstructured":"Cl\u00e9ment F, Belleville S. Test-retest reliability of fMRI verbal episodic memory paradigms in healthy older adults and in persons with mild cognitive impairment. Hum Brain Mapp. 2009, 30:4033-47. 10.1002\/hbm.20827","journal-title":"Hum Brain Mapp"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21166","article-title":"Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults","volume":"32","author":"Putcha D","year":"2011","unstructured":"Putcha D, O'Keefe K, LaViolette P, et al.. Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Hum Brain Mapp. 2011, 32:2027-44. 10.1002\/hbm.21166","journal-title":"Hum Brain Mapp"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6428-3","article-title":"Positron emission tomography imaging in neurological disorders","volume":"259","author":"Politis M","year":"2012","unstructured":"Politis M, Piccini P. Positron emission tomography imaging in neurological disorders. J Neurol. 2012, 259:1769-80. 10.1007\/s00415-012-6428-3","journal-title":"J Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2003.07.002","article-title":"Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons","volume":"20","author":"Rocher AB","year":"2003","unstructured":"Rocher AB, Chapon F, Blaizot X, Baron JC, Chavoix C. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 2003, 20:1894-8. 10.1016\/j.neuroimage.2003.07.002","journal-title":"Neuroimage"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2018.01.001","article-title":"Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease","volume":"194","author":"Liu X","year":"2018","unstructured":"Liu X, Chen K, Wu T, Weidman D, Lure F, Li J. Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease. Transl Res. 2018, 194:56-67. 10.1016\/j.trsl.2018.01.001","journal-title":"Transl Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-4580(01)00230-5","article-title":"Hippocampal formation glucose metabolism and volume losses in MCI and AD","volume":"22","author":"De Santi S","year":"2001","unstructured":"De Santi S, de Leon MJ, Rusinek H, et al.. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging. 2001, 22:529-39. 10.1016\/s0197-4580(01)00230-5","journal-title":"Neurobiol Aging"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima S","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997, 42:85-94. 10.1002\/ana.410420114","journal-title":"Ann Neurol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.33.8.961","article-title":"Alzheimer's disease: focal cortical changes shown by positron emission tomography","volume":"33","author":"Foster NL","year":"1983","unstructured":"Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology. 1983, 33:961-5. 10.1212\/wnl.33.8.961","journal-title":"Neurology"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman EM","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, et al.. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996, 334:752-8. 10.1056\/NEJM199603213341202","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04969-7","article-title":"Clinical impact of (18)F-FDG-PET among memory clinic patients with uncertain diagnosis","volume":"48","author":"Perini G","year":"2021","unstructured":"Perini G, Rodriguez-Vieitez E, Kadir A, Sala A, Savitcheva I, Nordberg A. Clinical impact of (18)F-FDG-PET among memory clinic patients with uncertain diagnosis. Eur J Nucl Med Mol Imaging. 2021, 48:612-22. 10.1007\/s00259-020-04969-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack CR Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, et al.. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-28. 10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180958","article-title":"A deep learning model to predict a diagnosis of Alzheimer disease by using (18)F-FDG PET of the brain","volume":"290","author":"Ding Y","year":"2019","unstructured":"Ding Y, Sohn JH, Kawczynski MG, et al.. A deep learning model to predict a diagnosis of Alzheimer disease by using (18)F-FDG PET of the brain. Radiology. 2019, 290:456-64. 10.1148\/radiol.2018180958","journal-title":"Radiology"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome","volume":"286","author":"Silverman DH","year":"2001","unstructured":"Silverman DH, Small GW, Chang CY, et al.. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001, 286:2120-7. 10.1001\/jama.286.17.2120","journal-title":"JAMA"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4032-1","article-title":"Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease","volume":"45","author":"Drzezga A","year":"2018","unstructured":"Drzezga A, Altomare D, Festari C, et al.. Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2018, 45:1487-96. 10.1007\/s00259-018-4032-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref63","article-title":"PET Scanning","author":"Kapoor M","year":"2022","unstructured":"Kapoor M, Kasi A. PET Scanning. StatPearls, Treasure Island; 2022."},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.06.1041","article-title":"P1- 291: hypometabolism patterns using FDG-PET in typical and atypical sporadic forms of early-onset Alzheimer\u2019s disease","volume":"12","author":"Vanhoutte M","year":"2016","unstructured":"Vanhoutte M, Lopes R, Maureille A, et al.. P1- 291: hypometabolism patterns using FDG-PET in typical and atypical sporadic forms of early-onset Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2016, 12:532. 10.1016\/j.jalz.2016.06.1041","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042110","article-title":"Imaging techniques in Alzheimer's disease: a review of applications in early diagnosis and longitudinal monitoring","volume":"22","author":"van Oostveen WM","year":"2021","unstructured":"van Oostveen WM, de Lange EC. Imaging techniques in Alzheimer's disease: a review of applications in early diagnosis and longitudinal monitoring. Int J Mol Sci. 2021, 22:10.3390\/ijms22042110","journal-title":"Int J Mol Sci"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0481-z","article-title":"Biomarkers for the early detection and progression of Alzheimer's disease","volume":"14","author":"Counts SE","year":"2017","unstructured":"Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ. Biomarkers for the early detection and progression of Alzheimer's disease. Neurotherapeutics. 2017, 14:35-53. 10.1007\/s13311-016-0481-z","journal-title":"Neurotherapeutics"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy JA","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992, 256:184-5. 10.1126\/science.1566067","journal-title":"Science"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.03.014","article-title":"Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer's disease","volume":"2","author":"Vandenberghe R","year":"2013","unstructured":"Vandenberghe R, Adamczuk K, Dupont P, Laere KV, Ch\u00e9telat G. Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin. 2013, 2:497-511. 10.1016\/j.nicl.2013.03.014","journal-title":"Neuroimage Clin"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9020065","article-title":"The who, when, why, and how of PET amyloid imaging in management of Alzheimer's disease-review of literature and interesting images","volume":"9","author":"Suppiah S","year":"2019","unstructured":"Suppiah S, Didier MA, Vinjamuri S. The who, when, why, and how of PET amyloid imaging in management of Alzheimer's disease-review of literature and interesting images. Diagnostics (Basel). 2019, 9:10.3390\/diagnostics9020065","journal-title":"Diagnostics (Basel)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk WE","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, et al.. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004, 55:306-19. 10.1002\/ana.20009","journal-title":"Ann Neurol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe CC","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U, et al.. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007, 68:1718-25. 10.1212\/01.wnl.0000261919.22630.ea","journal-title":"Neurology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000259035.98480.ed","article-title":"11C-PiB PET imaging in Alzheimer disease and frontotemporal lobar degeneration","volume":"68","author":"Rabinovici GD","year":"2007","unstructured":"Rabinovici GD, Furst AJ, O'Neil JP, et al.. 11C-PiB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007, 68:1205-12. 10.1212\/01.wnl.0000259035.98480.ed","journal-title":"Neurology"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark CM","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, et al.. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011, 305:275-83. 10.1001\/jama.2010.2008","journal-title":"JAMA"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong DF","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y, et al.. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010, 51:913-20. 10.2967\/jnumed.109.069088","journal-title":"J Nucl Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302548","article-title":"Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography","volume":"83","author":"Wolk DA","year":"2012","unstructured":"Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J Neurol Neurosurg Psychiatry. 2012, 83:923-6. 10.1136\/jnnp-2012-302548","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.05.038","article-title":"Comparison of [18F] flutemetamol and [11C] PiB PET images","volume":"10","author":"Ataka S","year":"2014","unstructured":"Ataka S, Takeda A, Mino T, et al.. Comparison of [18F] flutemetamol and [11C] PiB PET images. Alzheimer\u2019s Dement. 2014, 10:21. 10.1016\/j.jalz.2014.05.038","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for \u03b2-amyloid deposition in healthy aging: vascular and genetic effects","volume":"70","author":"Rodrigue KM","year":"2013","unstructured":"Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC. Risk factors for \u03b2-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 2013, 70:600-6. 10.1001\/jamaneurol.2013.1342","journal-title":"JAMA Neurol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.279","article-title":"Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report","volume":"66","author":"Cairns NJ","year":"2009","unstructured":"Cairns NJ, Ikonomovic MD, Benzinger T, et al.. Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report. Arch Neurol. 2009, 66:1557-62. 10.1001\/archneurol.2009.279","journal-title":"Arch Neurol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0172-1","article-title":"Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency","volume":"12","author":"Agadjanyan MG","year":"2017","unstructured":"Agadjanyan MG, Zagorski K, Petrushina I, et al.. Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency. Mol Neurodegener. 2017, 12:33. 10.1186\/s13024-017-0172-1","journal-title":"Mol Neurodegener"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(91)90105-4","article-title":"Molecular characterization of microtubule-associated proteins tau and MAP2","volume":"14","author":"Goedert M","year":"1991","unstructured":"Goedert M, Crowther RA, Garner CC. Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci. 1991, 14:193-9. 10.1016\/0166-2236(91)90105-4","journal-title":"Trends Neurosci"},{"key":"ref81","article-title":"Microtubule-associated protein tau. A component of Alzheimer's paired helical filaments","volume":"5","author":"Grundke-Iqbal I","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer's paired helical filaments. J Biol Chem. 1986, 5:6084-9.","journal-title":"J Biol Chem"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak H","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997, 18:351-7. 10.1016\/s0197-4580(97)00056-0","journal-title":"Neurobiol Aging"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada PV","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992, 42:631-9. 10.1212\/wnl.42.3.631","journal-title":"Neurology"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: current status and future directions","volume":"6","author":"Okamura N","year":"2018","unstructured":"Okamura N, Harada R, Ishiki A, Kikuchi A, Nakamura T, Kudo Y. The development and validation of tau PET tracers: current status and future directions. Clin Transl Imaging. 2018, 6:305-16. 10.1007\/s40336-018-0290-y","journal-title":"Clin Transl Imaging"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early progress and future directions","volume":"14","author":"Villemagne VL","year":"2015","unstructured":"Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. Lancet Neurol. 2015, 14:114-24. 10.1016\/S1474-4422(14)70252-2","journal-title":"Lancet Neurol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.04.013","article-title":"In vivo tau imaging: obstacles and progress","volume":"10","author":"Villemagne VL","year":"2014","unstructured":"Villemagne VL, Okamura N. In vivo tau imaging: obstacles and progress. Alzheimers Dement. 2014, 10:S254-64. 10.1016\/j.jalz.2014.04.013","journal-title":"Alzheimers Dement"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2017.03.001","article-title":"PET imaging for early detection of Alzheimer's disease: from pathologic to physiologic biomarkers","volume":"12","author":"Bao W","year":"2017","unstructured":"Bao W, Jia H, Finnema S, Cai Z, Carson RE, Huang YH. PET imaging for early detection of Alzheimer's disease: from pathologic to physiologic biomarkers. PET Clin. 2017, 12:329-50. 10.1016\/j.cpet.2017.03.001","journal-title":"PET Clin"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-018-1292-6","article-title":"SPECT and PET imaging in Alzheimer's disease","volume":"32","author":"Valotassiou V","year":"2018","unstructured":"Valotassiou V, Malamitsi J, Papatriantafyllou J, et al.. SPECT and PET imaging in Alzheimer's disease. Ann Nucl Med. 2018, 32:583-93. 10.1007\/s12149-018-1292-6","journal-title":"Ann Nucl Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00093","article-title":"Different positron emission tomography tau tracers bind to multiple binding sites on the tau fibril: insight from computational modeling","volume":"9","author":"Murugan NA","year":"2018","unstructured":"Murugan NA, Nordberg A, \u00c5gren H. Different positron emission tomography tau tracers bind to multiple binding sites on the tau fibril: insight from computational modeling. ACS Chem Neurosci. 2018, 9:1757-67. 10.1021\/acschemneuro.8b00093","journal-title":"ACS Chem Neurosci"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807","volume":"34","author":"Chien DT","year":"2013","unstructured":"Chien DT, Bahri S, Szardenings AK, et al.. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis. 2013, 34:457-68. 10.3233\/JAD-122059","journal-title":"J Alzheimers Dis"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3390\/biom6010007","article-title":"Characteristics of tau and its ligands in PET imaging","volume":"6","author":"Harada R","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y. Characteristics of tau and its ligands in PET imaging. Biomolecules. 2016, 6:7. 10.3390\/biom6010007","journal-title":"Biomolecules"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-22-08029.2003","article-title":"Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro","volume":"23","author":"Bresjanac M","year":"2003","unstructured":"Bresjanac M, Smid LM, Vovko TD, Petric A, Barrio JR, Popovic M. Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro. J Neurosci. 2003, 23:8029-33. 10.1523\/JNEUROSCI.23-22-08029.2003","journal-title":"J Neurosci"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","article-title":"Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease","volume":"21","author":"Agdeppa ED","year":"2001","unstructured":"Agdeppa ED, Kepe V, Liu J, et al.. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci. 2001, 21:RC189. 10.1523\/JNEUROSCI.21-24-j0004.2001","journal-title":"J Neurosci"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(02)00907-7","article-title":"In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile","author":"Agdeppa ED","year":"2003","unstructured":"Agdeppa ED, Kepe V, Petri A, et al.. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile. Neuroscience. 2003, 723-30. 10.1016\/s0306-4522(02)00907-7","journal-title":"Neuroscience"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama M","year":"2013","unstructured":"Maruyama M, Shimada H, Suhara T, et al.. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013, 79:1094-108. 10.1016\/j.neuron.2013.07.037","journal-title":"Neuron"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160127","article-title":"PET quantification of tau pathology in human brain with 11C-PBB3","volume":"56","author":"Kimura Y","year":"2015","unstructured":"Kimura Y, Ichise M, Ito H, et al.. PET quantification of tau pathology in human brain with 11C-PBB3. J Nucl Med. 2015, 56:1359-65. 10.2967\/jnumed.115.160127","journal-title":"J Nucl Med"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1738-05.2005","article-title":"Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease","volume":"25","author":"Okamura N","year":"2005","unstructured":"Okamura N, Suemoto T, Furumoto S, et al.. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. J Neurosci. 2005, 25:10857-62. 10.1523\/JNEUROSCI.1738-05.2005","journal-title":"J Neurosci"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease","volume":"134","author":"Fodero-Tavoletti MT","year":"2011","unstructured":"Fodero-Tavoletti MT, Okamura N, Furumoto S, et al.. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain. 2011, 134:1089-100. 10.1093\/brain\/awr038","journal-title":"Brain"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease","volume":"54","author":"Okamura N","year":"2013","unstructured":"Okamura N, Furumoto S, Harada R, et al.. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med. 2013, 54:1420-7. 10.2967\/jnumed.112.117341","journal-title":"J Nucl Med"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","author":"Harada R","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, et al.. 18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease. J Nucl Med. 2016, 57:208-14. 10.2967\/jnumed.115.164848","journal-title":"J Nucl Med"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers","volume":"16","author":"Frisoni GB","year":"2017","unstructured":"Frisoni GB, Boccardi M, Barkhof F, et al.. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Lancet Neurol. 2017, 16:661-76. 10.1016\/S1474-4422(17)30159-X","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128959-neuroimaging-in-alzheimers-disease-for-early-diagnosis-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:57:31Z","timestamp":1707490651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128959-neuroimaging-in-alzheimers-disease-for-early-diagnosis-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":101,"URL":"https:\/\/doi.org\/10.7759\/cureus.38544","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}